Shimizu Makiko, Origuchi Yumi, Ikuma Marika, Mitsuhashi Nanako, Yamazaki Hiroshi
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, 3-3165 Higashi-tamagawa Gakuen, Machida, Tokyo 194-8543, Japan.
Mol Genet Metab Rep. 2015 Nov 7;5:89-93. doi: 10.1016/j.ymgmr.2015.10.013. eCollection 2015 Dec.
Polymorphic human flavin-containing monooxygenase 3 (FMO3) is associated with the inherited disorder trimethylaminuria. Several FMO3 variants have been observed in a variety of ethnic groups, including a Japanese cohort suffering from trimethylaminuria. The aim of this study was to screen another self-reported Japanese trimethylaminuria cohort for novel FMO3 variants and to investigate these new variants. Subjects with low FMO3 metabolic capacities were identified by measuring the urinary trimethylamine and trimethylamine -oxide concentrationsin171 Japanese volunteers. The genes from these subjects and their family members were then sequenced. Heterozygotes or homozygotes for novel single-nucleotide polymorphisms c.20 T > C p.(Ile7Thr), c.122 G > A p.(Trp41Ter), c.127T > A p.(Phe43Ile), c.488 T > C p.(Leu163Pro), and c.1127G > A p.(Gly376Glu) and a heterozygote for the novel duplication c.850_860dupTTTAACGATGA p.(Glu287AspfsTer17) were identified. In addition, the known (but as yet uncharacterized) single-nucleotide polymorphism c.929 C > T p.(Ser310Leu) was found. Pedigree analysis revealed the p.(Ser310Leu) allele in configuration with c.929 C > T p.(Glu158Lys). These variant FMO3 proteins recombinantly expressed in membranes exhibited decreased -oxygenation activities toward trimethylamine and benzydamine. Although the allele frequencies of these seven variants were low, the present results suggest that individuals homozygous or heterozygous for any of these novel missense or duplication variants or known nonsense mutations such as p.(Cys197Ter) may possess abnormal activities toward trimethylamine -oxygenation.
多态性人类含黄素单加氧酶3(FMO3)与遗传性疾病三甲胺尿症相关。在包括患有三甲胺尿症的日本人群在内的各种种族群体中,已观察到几种FMO3变体。本研究的目的是在另一组自我报告的日本三甲胺尿症队列中筛选新的FMO3变体并研究这些新变体。通过测量171名日本志愿者尿液中三甲胺和三甲胺氧化物的浓度,鉴定出FMO3代谢能力较低的受试者。然后对这些受试者及其家庭成员的基因进行测序。鉴定出新型单核苷酸多态性c.20 T>C p.(Ile7Thr)、c.122 G>A p.(Trp41Ter)、c.127T>A p.(Phe43Ile)、c.488 T>C p.(Leu163Pro)和c.1127G>A p.(Gly376Glu)的杂合子或纯合子,以及新型重复c.850_860dupTTTAACGATGA p.(Glu287AspfsTer17)的杂合子。此外,还发现了已知(但尚未表征)的单核苷酸多态性c.929 C>T p.(Ser310Leu)。系谱分析显示p.(Ser310Leu)等位基因与c.929 C>T p.(Glu158Lys)处于连锁状态。在膜中重组表达的这些变体FMO3蛋白对三甲胺和苄达明的加氧活性降低。尽管这七个变体的等位基因频率较低,但目前的结果表明,对于这些新型错义或重复变体或已知无义突变(如p.(Cys197Ter))中的任何一种纯合或杂合的个体,可能对三甲胺加氧具有异常活性。